Core Insights - The company reported a significant increase in net profit and earnings per share for the fiscal year 2025, with net profit reaching 134.75 million yuan, a year-on-year growth of 745.02% [2][4] - Total revenue for the year was 1.19 billion yuan, remaining relatively stable compared to the previous year, with a slight decrease of 0.17% [3][4] Financial Performance - Operating profit was reported at 134.80 million yuan, showing a substantial increase of 1,574.60% compared to the previous year [3][4] - Total profit amounted to 134.77 million yuan, reflecting a year-on-year growth of 1,394.11% [3][4] - The basic earnings per share reached 2.59 yuan, marking a 735.48% increase from the previous year [3][4] - The weighted average return on net assets improved to 7.96%, an increase of 6.97 percentage points [3] Asset and Equity Growth - As of the end of 2025, total assets were reported at 2.21 billion yuan, a growth of 6.79% year-on-year [3] - Shareholder equity attributable to the listed company reached 1.79 billion yuan, increasing by 10.37% [3] - The net asset per share attributable to the parent company was 33.92 yuan, up by 8.51% [2] Operational Highlights - The company attributed its significant profit growth to improved profitability of core products and effective cost control measures [4] - New technologies, products, and projects have contributed to the company's steady business development, with successful launches of multiple products [4] - The reduction in stock incentive expenses and controlled R&D costs have also played a crucial role in enhancing operational profits [4]

Financial Performance Summary - The company achieved operating revenue of 1,193.74 million yuan, a slight decrease of 0.17% year-on-year [5] - Operating profit reached 134.80 million yuan, an increase of 1,574.60% year-on-year [5] - Total profit amounted to 134.77 million yuan, showing a year-on-year growth of 1,394.11% [5] - Net profit attributable to shareholders was 134.75 million yuan, up 745.02% year-on-year [5] - The net profit after deducting non-recurring gains and losses was 112.87 million yuan, reflecting a year-on-year increase of 1,602.73% [5] - Basic earnings per share were 2.59 yuan, a rise of 735.48% year-on-year [5] - As of the end of 2025, total assets were 2,208.80 million yuan, an increase of 6.79% year-on-year [5] - Shareholder equity attributable to the parent company was 1,787.63 million yuan, up 10.37% year-on-year [5] - The number of shares increased by 1.71% to 52.70 million shares [5] - Net asset value per share attributable to the parent company was 33.92 yuan, an increase of 8.51% year-on-year [5] Operational Factors - The company maintained steady business operations with breakthroughs in new technologies, products, customers, and projects [6] - Key products such as GECU, ZCU, and integrated solutions have been successfully launched, and self-manufactured injectors have begun mass production [6] - The increase in profit was primarily due to improved profitability of core products and effective cost control measures [6] - Continuous optimization of the supply chain and cost-reduction initiatives in R&D contributed to the improvement in core product profitability [6] - A significant reduction in stock incentive expenses and effective management of R&D costs also supported the growth in operating profit [6]

Core Viewpoint - The company reported a stable business performance with significant profit growth despite a slight decrease in revenue, indicating effective cost management and improved product profitability [1] Financial Performance - The company achieved an operating income of 1.194 billion yuan, a year-on-year decrease of 0.17% [1] - Net profit attributable to shareholders reached 135 million yuan, a year-on-year increase of 745.02% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 113 million yuan, showing a year-on-year growth of 1,602.73% [1] - Basic earnings per share were 2.59 yuan, reflecting a year-on-year increase of 735.48% [1] Business Development - The company continues to develop new technologies, products, customers, and projects, achieving breakthroughs with multiple products such as GECU, ZCU, and the four-in-one product [1] - The self-manufactured injector products have begun mass production and external supply [1] Cost Management - The significant increase in profit is attributed to improved profitability of core products and effective cost control measures [1] - The company has been optimizing its supply chain and implementing cost-reduction initiatives in research and development, leading to gradual improvement in core product profitability [1] - A substantial decrease in stock incentive expenses and reasonable control of R&D costs have also contributed to the growth in operating profit and related indicators [1]

Core Viewpoint - The company has maintained a development strategy focused on "customer passenger vehicle adaptation and product electrification" since its listing [1] Group 1: Company Strategy - The company supplies EMS products to various automotive manufacturers, including Li Auto, Leap Motor, and GAC, for their hybrid models [1] - The company is actively promoting the application of electrified products such as VCU, MCU/GCU, and GECU across more vehicle models [1]